Search
for
Sort by
Research 211–240 of 464
- Female hair loss
- Clinical pearls in dermatology 2018
- Skin Disorders in Athletes: Professional and Recreational Sports
- Poster session
- DRUG‐ASSOCIATED ALOPECIA
- Alopecia Areata Update
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Scalp Itch: A Systematic Review
- Complications in follicular unit excision hair transplantation: current evidence and practical approaches
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- British Society for Dermatopathology
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Diseases of Periocular Hair
- Platelet-rich Plasma for Hair Growth
- Effectiveness and safety of triple-diode laser with or without adjunctive topical eflornithine in female hirsutism
- Parasitic dermatitis in dogs: A literature review of clinical and diagnostic aspects and treatment approaches
- Drug-Induced Hair Changes
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- “PRIDE” Complex
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Chloracne: histopathologic findings in one case
- Malassezia Folliculitis
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Dermoscopy as an Auxiliary Tool in the Assessment of Malassezia Folliculitis: An Observational Study
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment